Integral Health Asset Management’s Unicycive Therapeutics UNCY Stock Holding History

Integral Health Asset Management’s Portfolio UNCY Stock Details UNCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.48M	Buy	+225,000	New	+$1.47M	0.07%	90

Other funds holding UNCY

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Integral Health Asset Management's UNCY Position: Q1 2026 in Review

Integral Health Asset Management opened a new position in Unicycive Therapeutics (UNCY) in Q1 2026: 225,000 shares worth $1.48M. The stake represents 0.07% of the portfolio and ranks #90 among its holdings.

51 funds tracked by Wall St. Rank hold UNCY as of Q1 2026.

Integral Health Asset Management held 225,000 shares of Unicycive Therapeutics worth $1.48M as of Q1 2026.
Unicycive Therapeutics was a new Integral Health Asset Management position in Q1 2026.
Unicycive Therapeutics made up 0.07% of Integral Health Asset Management's portfolio in Q1 2026, its #90 holding.
51 funds tracked by Wall St. Rank held Unicycive Therapeutics as of Q1 2026.

Based on Integral Health Asset Management's 13F filing for Q1 2026, filed 15 May 2026.